期刊文献+

糖尿病肾病患者血清脂联素水平的变化及与氧化应激的关系 被引量:4

Relationship between serum adiponectin and oxidative stress in diabeticnephropathy
下载PDF
导出
摘要 目的:探讨糖尿病肾病患者血清脂联素水平的变化及与氧化应激的关系。方法:分别测定35例糖尿病肾病患者、30例单纯糖尿病患者和30例正常对照者血清脂联素、丙二醛、超氧化物歧化酶水平。结果:糖尿病肾病患者较单纯糖尿病患者血清脂联素水平明显降低,血清丙二醛水平明显升高,血清超氧化物歧化酶水平明显降低(均P<0.01),糖尿病肾病患者血清脂联素水平与丙二醛水平呈明显负相关(r=-0.68,P<0.01),与超氧化物歧化酶水平呈明显正相关(r=0.54,P<0.01)。结论:糖尿病患者血清脂联素水平降低及所致的氧化应激增强在糖尿病肾病的发病中发挥重要作用。 Objective:To investigate the relationship between the change of serum adiponectin and the oxidative stress in diabetic nephropathy.Methods:The levels of serum adiponectin(APN),malonaldehyde(MDA) and superoxide dismulase(SOD) were measured in 35 cases of type 2 diabetie nephropathy,30 cases of type 2 diabetes with no nephropathy and 30 normal individuals as control.Results:The serum APN level was significantly lower than that with no nephropathy(P0.01),and the serum MDA level was significantly higher in diabetes with nephropathy than that with no nephropathy(P0.01) and the serum SOD level was significantly lower in the diabetes with nephropathy than that with no nephropathy(P0.01).A negative correlation was found between the serum APN level and the serum MDA level(r=-0.68,P0.01),a positive correlation was found between the serum APN level and the SOD serum(r=0.54,P0.01).Conclusion:The lowered serum APN level and the increased oxidative stress play an important role in the development of diabetic nephropathy.
出处 《黑龙江医药科学》 2010年第6期38-39,共2页 Heilongjiang Medicine and Pharmacy
关键词 糖尿病肾病 脂联素 丙二醛 超氧化物歧化酶 diabetic nephropathy adiponectin malonaldehyde superoxide dismulase
  • 相关文献

参考文献9

  • 1柴国禄,杨玉红,王艳秋,张尧杰,谭丽艳,庞建伟.糖尿病微血管病变患者血清脂联素水平变化及与脂质过氧化的关系[J].中国误诊学杂志,2009,9(16):3867-3868. 被引量:8
  • 2林纬,刘礼斌.脂联素的内皮保护效应[J].医学综述,2007,13(2):90-91. 被引量:8
  • 3JoussenAM,Poulaki V,Qin W,et al.Retina vasclar endothelial growth factor induces intercellular adhesion and initiates early dia-betic retinal leukocyte adhesion in vivo[J].Am J Pathol,2002.160(2):501-509.
  • 4Ouchi N,Rihara S,Arita Y.et al.Adiponeetion an adipocytederived plasma protein inhibits endothelial Nfkappa singnaling through a cAMP-dependent pathway[J].Circulation,2000,102(1):1296-1301.
  • 5Kobashi C,Orahaze M.Rishida M,et al.Adiponeetion inhibit-sEndothelial synthesis of interleukin-8[J].Cire Res,2005,97(12):1245-1252.
  • 6Bora PS,RaliappanS,Lyzogubor VV,et al.Expression of adiponee-tion Cheroidal tissue and inhibition of Laser indueed choroidalNeo-vascularization by adiponeetion[J].FEBB LETT,2007,581 (10):1977-1982.
  • 7Motashima H,Wu X.Mahader K,et al.Adiponeetion suppresses proliferation and superoxide generation and enhances e NOS activity in endothelial cells treated with oxidzed LDL[J].Biochem Biophyas Res Commun,2004,315(2):264-271.
  • 8Rueckschloss O,Galle J,Hohz J,et al.Induction of NAD(P)H oxi-dase by oxidized lowdensity lipoprotein in human endothelial cell;antioxidatire potential of ydroxymemethylglutaryl coenzyme a re-ductuse inhibitor therapy[J].Circulation,2001,104 (15):1797-1772.
  • 9Henniy B,Mecrarani P,Ramadss P,et al.Fatty acidmediated activa-tion of vascular endothelial cells[J].Metabolism,2001,40:1006-1013.

二级参考文献21

  • 1Ahma RS. Adipose tissue as an endocrine organ[J]. Obesity(Sib Spring), 2006,14 ($5) : 242-249.
  • 2Ouchi N ,Kihara S,Arita Y,et al. Adiponectin an adipocytederived plasma protein inhibrts endothelial NF kappa B signaling through a cAMP-dependent pathway [J]. Circulation, 2000,102 (1) : 1296- 1301.
  • 3Lhlann D,Gabel G,Ludwig S,et al. Effects of ET(A) receptor antagonism on proinflammatory gene expression and mierocirculation following hepatic ischemia/reperfusion [J]. Microcirculation,2005,12(5) :405-419.
  • 4Motoshima H, Wu X, Mahadev K, et al. Adiponectin suppresses proliferation and superoxide generation and enhances eNos activity in endothelial eells treated with oxidized LDL[J]. Bioehem Biophys Res Commun,2004,315(2) :264-271.
  • 5Henning B, Mecrarani P, Ramadss P, et al. Fatty acidmediated activation of vascular endothelial cells[J]. Metabolism, 2001,49 (3) : 1006-1013.
  • 6Okamoto Y,Kihara S, Ouchi N, et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice[J]. Circulation, 2002, 106(22) :2767-2770.
  • 7Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocytederived plasma protein, inhibits endothelial NFkappaB signaling through a cAMP-dependent pathway[J]. Circulation, 2000,102( 11 ) : 1296-1301.
  • 8Matsuda M, Shimomura I, Sata M, et al. Role of adiponectin in preventing vascular stenosis:the missing link of adipevascular axis[J] .J Biol Chem,2002,277(40) :37487-37491.
  • 9Ouchi N,Kihara S, Arita Y, et al. Adipecyte-derived plasma protein,adipenectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophnges[J ]. Circulation,2001,103(8) : 1057-1063.
  • 10Ouchi N,Kobayashi H, Kihara S, et al. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial calls[J] .J Biol Chem,2004,279(2) :1304-1309.

共引文献14

同被引文献53

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部